Showing results (1-10 of 17) with videos related to
Sort By:
Pageof 2
Biochimica Et Biophysica Acta. Molecular Cell Research|August 25, 2020
Negri bodies and other virus membrane-less replication compartmentsQuentin Nevers, Aurélie A Albertini, Cécile Lagaudrière-Gesbert, et al.Antiviral Research|October 23, 2025
Inhibition of influenza virus replication by artificial proteins (αReps) targeting its RNA-polymeraseMélissa Bessonne, Jessica Morel, Quentin Nevers, et al.Cell Reports|January 14, 2023
Rabies virus P protein binds to TBK1 and interferes with the formation of innate immunity-related liquid condensatesNathalie Scrima, Romain Le Bars, Quentin Nevers, et al.Plos Pathogens|June 14, 2024
Antiviral activity of intracellular nanobodies targeting the influenza virus RNA-polymerase coreMélissa Bessonne, Jessica Morel, Quentin Nevers, et al.Veterinary Research|November 5, 2025
Identification and characterization of a nonpeptidic cyclophilin ligand with antiviral activity against feline and porcine α-coronavirusesManon Delaplace, Mantasha Khan, Hélène Huet, et al.Plos Pathogens|December 8, 2022
Properties of rabies virus phosphoprotein and nucleoprotein biocondensates formed in vitro and in celluloQuentin Nevers, Nathalie Scrima, Damien Glon, et al.Antimicrobial Agents and Chemotherapy|May 8, 2020
Inhibition of SARS-CoV-2 Infection by the Cyclophilin Inhibitor Alisporivir (Debio 025)Laurent Softic, Rozenn Brillet, François Berry, et al.Antimicrobial Agents and Chemotherapy|March 18, 2020
MK-571, a Cysteinyl Leukotriene Receptor 1 Antagonist, Inhibits Hepatitis C Virus ReplicationIsaac Ruiz, Quentin Nevers, Eva Hernández, et al.Antimicrobial Agents and Chemotherapy|July 17, 2026
Optimization of the antiviral spectrum of cyclophilin inhibitors targeting respiratory virusesLaurent Softic, Bryan Jimenez-Araya, Nazim Ahnou, et al.Virology|March 25, 2026
A spike-binding protein as a versatile tool to detect and inhibit transmissible gastroenteritis virusMantasha Khan, Nathalie Lejal, Fanny Boursin, et al.Pageof 2